10-Q Filing

ENVERIC BIOSCIENCES, INC. CIK: 890821 Q3 2022

Filing Information

Form Type	10-Q
Accession Number	`0001493152-22-032131`
Period End Date	20220930
Filing Date	20221114
Fiscal Year	2022
Fiscal Period	Q3
XBRL Instance	form10-q_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 79 Income Statement 84 Cash Flow Statement 102 Stockholders Equity 69

Balance Sheet 79 line items

Line Item	Tag	Value	Unit	Period
Cash	`Cash`	$21.20M	USD	Point-in-time
Cash	`Cash`	$17.36M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$380.84K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$1.07M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$22.27M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$17.74M	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	20.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	20.00M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$712.94K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$294.43K	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	20.00M	shares	Point-in-time
Right-of-use operating lease asset	`OperatingLeaseRightOfUseAsset`	$88.77K	USD	Point-in-time
Right-of-use operating lease asset	`OperatingLeaseRightOfUseAsset`	$176.30K	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$6.32M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$6.92M	USD	Point-in-time
Goodwill	`Goodwill`	$1.59M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Goodwill	`Goodwill`	$1.47M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Total other assets	`AssetsNoncurrent`	$8.98M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Total other assets	`AssetsNoncurrent`	$8.59M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	651,921.00	shares	Point-in-time
Total assets	`Assets`	$26.72M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	2.08M	shares	Point-in-time
Total assets	`Assets`	$30.86M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	651,921.00	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	2.08M	shares	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$710.31K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$683.39K	USD	Point-in-time
Accrued liabilities	`AccruedLiabilitiesCurrent`	$1.29M	USD	Point-in-time
Accrued liabilities	`AccruedLiabilitiesCurrent`	$1.11M	USD	Point-in-time
Current portion of right-of-use operating lease obligation	`OperatingLeaseLiabilityCurrent`	$88.77K	USD	Point-in-time
Current portion of right-of-use operating lease obligation	`OperatingLeaseLiabilityCurrent`	$107.44K	USD	Point-in-time
Derivative liability	`DerivativeLiabilitiesCurrent`	$686.00K	USD	Point-in-time
Derivative liability	`DerivativeLiabilitiesCurrent`	-	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.08M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.60M	USD	Point-in-time
Non-current portion of right-of-use operating lease obligation	`OperatingLeaseLiabilityNoncurrent`	-	USD	Point-in-time
Non-current portion of right-of-use operating lease obligation	`OperatingLeaseLiabilityNoncurrent`	$68.86K	USD	Point-in-time
Deferred tax liability	`DeferredIncomeTaxLiabilities`	$1.61M	USD	Point-in-time
Deferred tax liability	`DeferredIncomeTaxLiabilities`	$1.49M	USD	Point-in-time
Investment option liability	`OtherLiabilitiesNoncurrent`	-	USD	Point-in-time
Investment option liability	`OtherLiabilitiesNoncurrent`	$2.51M	USD	Point-in-time
Warrant liability	`WarrantLiabilitiesNoncurrent`	$654.94K	USD	Point-in-time
Warrant liability	`WarrantLiabilitiesNoncurrent`	$653.67K	USD	Point-in-time
Total non-current liabilities	`LiabilitiesNoncurrent`	$2.33M	USD	Point-in-time
Total non-current liabilities	`LiabilitiesNoncurrent`	$4.66M	USD	Point-in-time
Total liabilities	`Liabilities`	$7.25M	USD	Point-in-time
Total liabilities	`Liabilities`	$4.41M	USD	Point-in-time
Commitments and contingencies (Note 7)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 7)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Redeemable non-controlling interest	`RedeemableNoncontrollingInterestEquityCarryingAmount`	-	USD	Point-in-time
Redeemable non-controlling interest	`RedeemableNoncontrollingInterestEquityCarryingAmount`	$761.43K	USD	Point-in-time
Total mezzanine equity	`TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests`	-	USD	Point-in-time
Total mezzanine equity	`TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests`	$761.43K	USD	Point-in-time
Preferred stock, $0.01 par value, 20,000,000 shares authorized; Series B preferred stock, $0.01 par value, 3,600,000 shares authorized, 0 shares issued and outstanding as of September 30, 2022 and December 31, 2021	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.01 par value, 20,000,000 shares authorized; Series B preferred stock, $0.01 par value, 3,600,000 shares authorized, 0 shares issued and outstanding as of September 30, 2022 and December 31, 2021	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.01 par value, 100,000,000 shares authorized, 2,078,271 and 651,921 shares issued and outstanding as of September 30, 2022 and December 31, 2021, respectively	`CommonStockValue`	$6.52K	USD	Point-in-time
Common stock, $0.01 par value, 100,000,000 shares authorized, 2,078,271 and 651,921 shares issued and outstanding as of September 30, 2022 and December 31, 2021, respectively	`CommonStockValue`	$20.78K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$93.99M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$83.07M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-60.74M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-70.53M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-30.80K	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-640.50K	USD	Point-in-time
Total shareholders equity	`StockholdersEquity`	$21.97M	USD	Point-in-time
Total shareholders equity	`StockholdersEquity`	$55.37M	USD	Point-in-time
Total shareholders equity	`StockholdersEquity`	$24.44M	USD	Point-in-time
Total shareholders equity	`StockholdersEquity`	$18.82M	USD	Point-in-time
Total shareholders equity	`StockholdersEquity`	$22.31M	USD	Point-in-time
Total shareholders equity	`StockholdersEquity`	$18.99M	USD	Point-in-time
Total shareholders equity	`StockholdersEquity`	$22.84M	USD	Point-in-time
Total shareholders equity	`StockholdersEquity`	$3.42M	USD	Point-in-time
Total liabilities, mezzanine equity, and shareholders equity	`LiabilitiesAndStockholdersEquity`	$30.86M	USD	Point-in-time
Total liabilities, mezzanine equity, and shareholders equity	`LiabilitiesAndStockholdersEquity`	$26.72M	USD	Point-in-time

Income Statement 84 line items

Line Item	Tag	Value	Unit	Period
General and administrative	`GeneralAndAdministrativeExpense`	$10.86M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$2.12M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$3.51M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$8.78M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$2.06M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$1.22M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$2.30M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$6.13M	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$484.36K	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$173.70K	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$86.65K	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$241.41K	USD	3 Qtrs
Total operating expenses	`OperatingCostsAndExpenses`	$5.66M	USD	1 Quarter
Total operating expenses	`OperatingCostsAndExpenses`	$13.64M	USD	3 Qtrs
Total operating expenses	`OperatingCostsAndExpenses`	$3.52M	USD	1 Quarter
Total operating expenses	`OperatingCostsAndExpenses`	$15.16M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-5.66M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-15.16M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-13.64M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-3.52M	USD	1 Quarter
Inducement expense	`InducementExpense`	$298.71K	USD	3 Qtrs
Inducement expense	`InducementExpense`	-	USD	1 Quarter
Inducement expense	`InducementExpense`	-	USD	3 Qtrs
Inducement expense	`InducementExpense`	-	USD	1 Quarter
Change in fair value of warrant liabilities	`FairValueAdjustmentOfWarrants`	$-1.60M	USD	1 Quarter
Change in fair value of warrant liabilities	`FairValueAdjustmentOfWarrants`	$-804.83K	USD	1 Quarter
Change in fair value of warrant liabilities	`FairValueAdjustmentOfWarrants`	$-3.85M	USD	3 Qtrs
Change in fair value of warrant liabilities	`FairValueAdjustmentOfWarrants`	$-7.08M	USD	3 Qtrs
Change in fair value of investment option liability	`GainLossOnInvestments`	$1.81M	USD	1 Quarter
Change in fair value of investment option liability	`GainLossOnInvestments`	-	USD	1 Quarter
Change in fair value of investment option liability	`GainLossOnInvestments`	$1.81M	USD	3 Qtrs
Change in fair value of investment option liability	`GainLossOnInvestments`	-	USD	3 Qtrs
Change in fair value of derivative liability	`DerivativeGainLossOnDerivativeNet`	-	USD	3 Qtrs
Change in fair value of derivative liability	`DerivativeGainLossOnDerivativeNet`	$-231.00K	USD	1 Quarter
Change in fair value of derivative liability	`DerivativeGainLossOnDerivativeNet`	-	USD	1 Quarter
Change in fair value of derivative liability	`DerivativeGainLossOnDerivativeNet`	$-284.00K	USD	3 Qtrs
Interest expense	`InterestExpense`	$308.00	USD	1 Quarter
Interest expense	`InterestExpense`	$5.11K	USD	3 Qtrs
Interest expense	`InterestExpense`	$370.00	USD	1 Quarter
Interest expense	`InterestExpense`	$5.19K	USD	3 Qtrs
Total other income	`NonoperatingIncomeExpense`	$3.18M	USD	1 Quarter
Total other income	`NonoperatingIncomeExpense`	$804.46K	USD	1 Quarter
Total other income	`NonoperatingIncomeExpense`	$6.77M	USD	3 Qtrs
Total other income	`NonoperatingIncomeExpense`	$5.37M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-6.87M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-3.25M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-4.52M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-9.79M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-2.79M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.48M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.71M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-908.29K	USD	1 Quarter
Less preferred dividends attributable to non-controlling interest	`PreferredStockDividendsIncomeStatementImpact`	-	USD	3 Qtrs
Less preferred dividends attributable to non-controlling interest	`PreferredStockDividendsIncomeStatementImpact`	$12.60K	USD	1 Quarter
Less preferred dividends attributable to non-controlling interest	`PreferredStockDividendsIncomeStatementImpact`	-	USD	1 Quarter
Less preferred dividends attributable to non-controlling interest	`PreferredStockDividendsIncomeStatementImpact`	$20.41K	USD	3 Qtrs
Less deemed dividends attributable to accretion of embedded derivative at redemption value	`TemporaryEquityAccretionToRedemptionValueAdjustment`	-	USD	3 Qtrs
Less deemed dividends attributable to accretion of embedded derivative at redemption value	`TemporaryEquityAccretionToRedemptionValueAdjustment`	$110.99K	USD	1 Quarter
Less deemed dividends attributable to accretion of embedded derivative at redemption value	`TemporaryEquityAccretionToRedemptionValueAdjustment`	-	USD	1 Quarter
Less deemed dividends attributable to accretion of embedded derivative at redemption value	`TemporaryEquityAccretionToRedemptionValueAdjustment`	$184.99K	USD	3 Qtrs
Net loss attributable to shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-6.87M	USD	3 Qtrs
Net loss attributable to shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-2.60M	USD	1 Quarter
Net loss attributable to shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-2.71M	USD	1 Quarter
Net loss attributable to shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-10.00M	USD	3 Qtrs
Foreign currency translation	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$35.74K	USD	1 Quarter
Foreign currency translation	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$88.71K	USD	1 Quarter
Foreign currency translation	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-281.01K	USD	1 Quarter
Foreign currency translation	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-417.39K	USD	1 Quarter
Foreign currency translation	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-33.26K	USD	1 Quarter
Foreign currency translation	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-6.51K	USD	1 Quarter
Foreign currency translation	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-609.70K	USD	3 Qtrs
Foreign currency translation	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-4.04K	USD	3 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-3.02M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-2.72M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-6.88M	USD	3 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-10.61M	USD	3 Qtrs
Net loss per share - basic and diluted	`EarningsPerShareBasic`	$-16.64	USD	3 Qtrs
Net loss per share - basic and diluted	`EarningsPerShareBasic`	$-8.11	USD	3 Qtrs
Net loss per share - basic and diluted	`EarningsPerShareBasic`	$-5.91	USD	1 Quarter
Net loss per share - basic and diluted	`EarningsPerShareBasic`	$-1.46	USD	1 Quarter
Weighted average shares outstanding, basic and diluted	`WeightedAverageNumberOfSharesOutstandingBasic`	459,289.00	shares	1 Quarter
Weighted average shares outstanding, basic and diluted	`WeightedAverageNumberOfSharesOutstandingBasic`	1.79M	shares	1 Quarter
Weighted average shares outstanding, basic and diluted	`WeightedAverageNumberOfSharesOutstandingBasic`	1.23M	shares	3 Qtrs
Weighted average shares outstanding, basic and diluted	`WeightedAverageNumberOfSharesOutstandingBasic`	413,063.00	shares	3 Qtrs

Cash Flow Statement 102 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-6.87M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-3.25M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-4.52M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-9.79M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-2.79M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.48M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.71M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-908.29K	USD	1 Quarter
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$-1.60M	USD	1 Quarter
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$-804.83K	USD	1 Quarter
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$-3.85M	USD	3 Qtrs
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$-7.08M	USD	3 Qtrs
Change in fair value of investment option liability	`GainLossOnInvestments`	$1.81M	USD	1 Quarter
Change in fair value of investment option liability	`GainLossOnInvestments`	-	USD	1 Quarter
Change in fair value of investment option liability	`GainLossOnInvestments`	$1.81M	USD	3 Qtrs
Change in fair value of investment option liability	`GainLossOnInvestments`	-	USD	3 Qtrs
Change in fair value of derivative liability	`DerivativeGainLossOnDerivativeNet`	-	USD	3 Qtrs
Change in fair value of derivative liability	`DerivativeGainLossOnDerivativeNet`	$-231.00K	USD	1 Quarter
Change in fair value of derivative liability	`DerivativeGainLossOnDerivativeNet`	-	USD	1 Quarter
Change in fair value of derivative liability	`DerivativeGainLossOnDerivativeNet`	$-284.00K	USD	3 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$2.09M	USD	3 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$4.83M	USD	3 Qtrs
Inducement expense	`InducementExpense`	$298.71K	USD	3 Qtrs
Inducement expense	`InducementExpense`	-	USD	1 Quarter
Inducement expense	`InducementExpense`	-	USD	3 Qtrs
Inducement expense	`InducementExpense`	-	USD	1 Quarter
Amortization of right-of-use asset	`OperatingLeaseRightOfUseAssetAmortizationExpense`	-	USD	3 Qtrs
Amortization of right-of-use asset	`OperatingLeaseRightOfUseAssetAmortizationExpense`	$103.36K	USD	3 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$42.19K	USD	1 Quarter
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$126.56K	USD	3 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$170.69K	USD	1 Quarter
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$482.12K	USD	3 Qtrs
Depreciation expense	`Depreciation`	$114.85K	USD	3 Qtrs
Depreciation expense	`Depreciation`	$2.24K	USD	3 Qtrs
Depreciation expense	`Depreciation`	$44.46K	USD	1 Quarter
Depreciation expense	`Depreciation`	$2.24K	USD	1 Quarter
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$758.42K	USD	3 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-320.12K	USD	3 Qtrs
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-106.67K	USD	3 Qtrs
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$625.75K	USD	3 Qtrs
Right-of-use operating lease liability	`IncreaseDecreaseInRightOfUseLeaseLiability`	-	USD	3 Qtrs
Right-of-use operating lease liability	`IncreaseDecreaseInRightOfUseLeaseLiability`	$91.02K	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-7.39M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-13.68M	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$577.97K	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	-	USD	3 Qtrs
Purchase of Diverse Bio license agreement	`PaymentsToAcquireIntangibleAssets`	$675.00K	USD	3 Qtrs
Purchase of Diverse Bio license agreement	`PaymentsToAcquireIntangibleAssets`	-	USD	3 Qtrs
Cash accretive acquisition of MagicMed	`ProceedsFromAmalgamationAgreement`	-	USD	3 Qtrs
Cash accretive acquisition of MagicMed	`ProceedsFromAmalgamationAgreement`	$3.06M	USD	3 Qtrs
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-577.97K	USD	3 Qtrs
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$2.38M	USD	3 Qtrs
Proceeds from sale of common stock, warrants, and investment options, net of offering costs	`ProceedsFromIssuanceOfCommonStock`	$21.61M	USD	3 Qtrs
Proceeds from sale of common stock, warrants, and investment options, net of offering costs	`ProceedsFromIssuanceOfCommonStock`	$17.22M	USD	3 Qtrs
Proceeds from the sale of redeemable non-controlling interest, net of offering costs (see Note 6)	`ProceedsFromMinorityShareholders`	-	USD	3 Qtrs
Proceeds from the sale of redeemable non-controlling interest, net of offering costs (see Note 6)	`ProceedsFromMinorityShareholders`	$958.04K	USD	3 Qtrs
Proceeds from warrant exercises, net of fees	`ProceedsFromWarrantExercises`	$3.29M	USD	3 Qtrs
Proceeds from warrant exercises, net of fees	`ProceedsFromWarrantExercises`	-	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$18.18M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$24.90M	USD	3 Qtrs
Effect of foreign exchange rate on cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$-19.66K	USD	3 Qtrs
Effect of foreign exchange rate on cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$-72.55K	USD	3 Qtrs
Net increase in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$3.85M	USD	3 Qtrs
Net increase in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$19.87M	USD	3 Qtrs
Cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$1.58M	USD	Point-in-time
Cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$17.36M	USD	Point-in-time
Cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$21.45M	USD	Point-in-time
Cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$21.20M	USD	Point-in-time
Cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$1.58M	USD	Point-in-time
Cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$17.36M	USD	Point-in-time
Cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$21.45M	USD	Point-in-time
Cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$21.20M	USD	Point-in-time
Cash paid for interest	`InterestPaidNet`	$5.19K	USD	3 Qtrs
Cash paid for interest	`InterestPaidNet`	$5.11K	USD	3 Qtrs
Income taxes paid	`IncomeTaxesPaidNet`	-	USD	3 Qtrs
Income taxes paid	`IncomeTaxesPaidNet`	-	USD	3 Qtrs
Investment options issued in conjunction with common stock issuance	`InvestmentOptionsIssuedInConjunctionWithCommonStockIssuance`	-	USD	3 Qtrs
Investment options issued in conjunction with common stock issuance	`InvestmentOptionsIssuedInConjunctionWithCommonStockIssuance`	$4.32M	USD	3 Qtrs
Modification of warrants as part of share capital raise	`ModificationOfWarrantsAsPartOfShareCapitalRaise`	-	USD	3 Qtrs
Modification of warrants as part of share capital raise	`ModificationOfWarrantsAsPartOfShareCapitalRaise`	$251.36K	USD	3 Qtrs
Warrants issued in conjunction with common stock issuance	`WarrantsIssuedInConjunctionWithNotesPayable`	$3.60M	USD	3 Qtrs
Warrants issued in conjunction with common stock issuance	`WarrantsIssuedInConjunctionWithNotesPayable`	-	USD	3 Qtrs
Issuance of embedded derivative	`IssuanceOfEmbeddedDerivative`	-	USD	3 Qtrs
Issuance of embedded derivative	`IssuanceOfEmbeddedDerivative`	$402.00K	USD	3 Qtrs
Preferred dividends attributable to redeemable non-controlling interest	`PreferredDividendsAttributableToRedeemableNoncontrollingInterest`	-	USD	3 Qtrs
Preferred dividends attributable to redeemable non-controlling interest	`PreferredDividendsAttributableToRedeemableNoncontrollingInterest`	$-12.60K	USD	1 Quarter
Preferred dividends attributable to redeemable non-controlling interest	`PreferredDividendsAttributableToRedeemableNoncontrollingInterest`	$-7.81K	USD	1 Quarter
Preferred dividends attributable to redeemable non-controlling interest	`PreferredDividendsAttributableToRedeemableNoncontrollingInterest`	$20.41K	USD	3 Qtrs
Accretion of embedded derivative to redemption value	`AccretionOfEmbeddedDerivativeToRedemptionValue`	$184.99K	USD	3 Qtrs
Accretion of embedded derivative to redemption value	`AccretionOfEmbeddedDerivativeToRedemptionValue`	-	USD	3 Qtrs
Accretion of embedded derivative to redemption value	`AccretionOfEmbeddedDerivativeToRedemptionValue`	$-73.99K	USD	1 Quarter
Accretion of embedded derivative to redemption value	`AccretionOfEmbeddedDerivativeToRedemptionValue`	$-110.99K	USD	1 Quarter
Issuance of Common Stock pursuant to MagicMed amalgamation	`IssuanceOfCommonStockPursuantToAmalgamation`	$39.04M	USD	3 Qtrs
Issuance of Common Stock pursuant to MagicMed amalgamation	`IssuanceOfCommonStockPursuantToAmalgamation`	-	USD	3 Qtrs
Deferred tax liability incurred due to MagicMed amalgamation	`DeferredTaxLiabilityIncurredDueToAmalgamation`	$9.06M	USD	3 Qtrs
Deferred tax liability incurred due to MagicMed amalgamation	`DeferredTaxLiabilityIncurredDueToAmalgamation`	-	USD	3 Qtrs
Conversion of preferred stock to common stock	`ConversionOfPreferredStockToCommonStock`	-	USD	3 Qtrs
Conversion of preferred stock to common stock	`ConversionOfPreferredStockToCommonStock`	$32.75K	USD	3 Qtrs
Fair value of warrants issued	`FairValueOfWarrantsIssued`	$9.98M	USD	3 Qtrs
Fair value of warrants issued	`FairValueOfWarrantsIssued`	-	USD	3 Qtrs
Fair value of Ameri warrants	`FairValueOfWarrants`	-	USD	3 Qtrs
Fair value of Ameri warrants	`FairValueOfWarrants`	$262.49K	USD	3 Qtrs

Stockholders Equity 69 line items

Line Item	Tag	Value	Unit	Period
Redeemable noncontrolling interest embedded derivative	`RedeemableNoncontrollingInterestEmbeddedDerivative`	$402.00K	USD	3 Qtrs
Redeemable noncontrolling interest issuance costs	`RedeemableNoncontrollingInterestIssuanceCosts`	$41.96K	USD	3 Qtrs
Beginning balance	`StockholdersEquity`	$21.97M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$55.37M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$24.44M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$18.82M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$22.31M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$18.99M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$22.84M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$3.42M	USD	Point-in-time
January 2021 registered direct offering, net of offering costs	`StockIssuedDuringPeriodValueIssuedDirectOfferingNet`	$4.62M	USD	1 Quarter
February registered direct offering, net of offering costs	`StockIssuedDuringPeriodValueIssuedDirectOfferingNetOne`	$7.02M	USD	1 Quarter
February registered direct offering, net of offering costs	`StockIssuedDuringPeriodValueIssuedDirectOfferingNetOne`	$5.80M	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$645.14K	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$486.99K	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$750.93K	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$3.59M	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$768.62K	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$677.54K	USD	1 Quarter
Induced conversion of stock options into restricted stock awards	`AdjustmentToAdditionalPaidInCapitalConvertibleDebtInstrumentIssuedAtSubstantialPremium`	$298.71K	USD	1 Quarter
Conversion of Series B Preferred Stock	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	-	USD	1 Quarter
Exercise of warrants	`StockIssuedDuringPeriodValueWarrantsExercised`	$3.27M	USD	1 Quarter
Exercise of warrants	`StockIssuedDuringPeriodValueWarrantsExercised`	$17.93K	USD	1 Quarter
Foreign exchange translation gain (loss)	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$35.74K	USD	1 Quarter
Foreign exchange translation gain (loss)	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$88.71K	USD	1 Quarter
Foreign exchange translation gain (loss)	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-281.01K	USD	1 Quarter
Foreign exchange translation gain (loss)	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-417.39K	USD	1 Quarter
Foreign exchange translation gain (loss)	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-33.26K	USD	1 Quarter
Foreign exchange translation gain (loss)	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-6.51K	USD	1 Quarter
Foreign exchange translation gain (loss)	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-609.70K	USD	3 Qtrs
Foreign exchange translation gain (loss)	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-4.04K	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-6.87M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-3.25M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-4.52M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-9.79M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-2.79M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.48M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.71M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-908.29K	USD	1 Quarter
Conversion of stock options into restricted stock	`StockIssuedDuringPeriodValueRestrictedStockAwardGross`	-	USD	1 Quarter
Exercise of options	`StockIssuedDuringPeriodValueStockOptionsExercised`	-	USD	1 Quarter
Consideration paid pursuant to amalgamation agreement	`ConsiderationPaidPursuantToAmalgamationAgreement`	$39.04M	USD	1 Quarter
Reserve for Ameri warrant liabilities	`ReserveForAmeriWarrantLiabilities`	$-262.49K	USD	1 Quarter
Conversion of RSAs into common shares	`StockIssuedDuringPeriodValueConversionOfUnits`	-	USD	1 Quarter
Conversion of RSAs into common shares	`StockIssuedDuringPeriodValueConversionOfUnits`	-	USD	1 Quarter
Redeemable non-controlling interest, net of $402,000 embedded derivative and net of issuance costs of $41,962	`RedeemableNoncontrollingInterestEmbeddedDerivativeAndNetOfIssuanceCosts`	-	USD	1 Quarter
Redeemable noncontrolling interest, net of $402,000 embedded derivative and net of issuance costs of $41,962, shares	`RedeemableNoncontrollingInterestEmbeddedDerivativeAndNetOfIssuanceCostsShares`	556,038.00	shares	3 Qtrs
Issuance of redeemable Series C preferred stock	`IssuanceOfRedeemableNoncontrollingSeriesPreferredStock`	$-527.00	USD	1 Quarter
Preferred dividends attributable to redeemable non-controlling interest	`PreferredDividendsAttributableToRedeemableNoncontrollingInterest`	-	USD	3 Qtrs
Preferred dividends attributable to redeemable non-controlling interest	`PreferredDividendsAttributableToRedeemableNoncontrollingInterest`	$-12.60K	USD	1 Quarter
Preferred dividends attributable to redeemable non-controlling interest	`PreferredDividendsAttributableToRedeemableNoncontrollingInterest`	$-7.81K	USD	1 Quarter
Preferred dividends attributable to redeemable non-controlling interest	`PreferredDividendsAttributableToRedeemableNoncontrollingInterest`	$20.41K	USD	3 Qtrs
Accretion of embedded derivative to redemption value	`AccretionOfEmbeddedDerivativeToRedemptionValue`	$184.99K	USD	3 Qtrs
Accretion of embedded derivative to redemption value	`AccretionOfEmbeddedDerivativeToRedemptionValue`	-	USD	3 Qtrs
Accretion of embedded derivative to redemption value	`AccretionOfEmbeddedDerivativeToRedemptionValue`	$-73.99K	USD	1 Quarter
Accretion of embedded derivative to redemption value	`AccretionOfEmbeddedDerivativeToRedemptionValue`	$-110.99K	USD	1 Quarter
Accretion of embedded derivative to redemption value, shares	`AccretionOfEmbeddedDerivativeToRedemptionShares`	-	shares	1 Quarter
Accretion of embedded derivative to redemption value, shares	`AccretionOfEmbeddedDerivativeToRedemptionShares`	-	shares	1 Quarter
July 2022 registered direct offering, PIPE offering, modification of warrants and exercise of pre-funded warrants, net of offering costs	`RegisteredDirectOfferingPipeOfferingModificationOfWarrantsAndExerciseOfPrefundedWarrantsNetOfOfferingCosts`	$3.25M	USD	1 Quarter
Issuance of rounded shares as a result of the reverse stock split	`IssuanceOfRoundedSharesAsResultOfReverseStockSplit`	-	USD	1 Quarter
Redemption of Series C preferred stock	`StockRedeemedOrCalledDuringPeriodValue`	$527.00	USD	1 Quarter
Ending balance	`StockholdersEquity`	$21.97M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$55.37M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$24.44M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$18.82M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$22.31M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$18.99M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$22.84M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$3.42M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.